Using the same mRNA technology as Covid vaccinations, UK scientists may have developed the world's first treatment for heart attacks. After a cardiac attack, the human heart has no ability to mend itself.
However, a new technique called genetic monitoring, which is based on the same technology as Pfizer and Moderna's Covid vaccinations, can enable new heart cells replace the dead ones and generate new muscle tissue instead of developing a scar. A team from King's College London tracked genetic codes called mRNAs, which are delivered into the heart to build proteins that generate healthy cardiac cells.
"We all have the same number of muscle cells in our hearts when we are born, and they are the same ones we shall have when we die." Professor Mauro Giacca, the lead researcher, was reported as saying, "Our goal has been to identify a treatment that can convince surviving cells to proliferate." "Until recently, regenerating a damaged human heart was a pipe dream, but it is now a possibility. "We're injecting micro RNAs into the heart using the same technique as Pfizer and Moderna vaccines, accessing surviving heart cells and boosting their multiplication," Giacca added.
The mRNAs work towards a treatment to prevent cells from dying during a heart attack, in addition to helping hearts regenerate.
Lancet study finds Heart inflammation risk post Covid-19 vaccination rare
If there is a headache in the morning, it may be a brain tumor
